GENENTECH SETS 100 MLN DLRS OF CONVERTIBLE BONDS LONDON MARCH 11 GENETECH INC  GENEO IS ISSUING A 100 MLN DLR CONVERTIBLE BOND DUE MARCH 30 2002 WITH AN INDICATED COUPON OF FIVE TO 5 1 2 PCT AND AN ISSUE PRICE OF PAR CREDIT SUISSE FIRST BOSTON CSFB SAID AS LEAD MANAGER GENENTECH'S STOCK CLOSED AT 58 5 8 ON THE NEW YORK STOCK EXCHANGE LAST NIGHT CSFB SAID FINAL TERMS TO BE SET AROUND MARCH 12 ANTICIPATE A CONVERSION PREMIUM OF 20 TO 25 PCT THE SECURITIES WILL BE AVAILABLE IN BEARER OR REGISTERED FORM IN DENOMINATIONS OF 5000 DLRS EACH THE DEAL IS CALLABLE IMMEDIATELY AT 106 FOR THE FIRST THREE YEARS DECLINING BY ONE PCT PER YEAR EACH YEAR THEREAFTER  HOWEVER IF THE STOCK PRICE RISES TO MORE THAN 130 PCT OF THE CONVERSION LEVEL THE ISSUE WILL BE CALLABLE IMMEDIATELY CSFB SAID PAINEWEBBER IS CO LEAD MANAGER FEES CONSIST OF A 1 1 2 PCT SELLING CONCESSION AND A ONE PCT COMBINED MANAGEMENT AND UNDERWRITING FEE   